Milestone Pharmaceuticals
MIST
#9234
Rank
A$0.21 B
Marketcap
A$1.72
Share price
-2.44%
Change (1 day)
-24.53%
Change (1 year)

Revenue for Milestone Pharmaceuticals (MIST)

Revenue in 2026 (TTM): A$2.65 Million

According to Milestone Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is A$2.55 Million. In 2025 the company made a revenue of A$2.3 Million an increase over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Milestone Pharmaceuticals from 2018 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) A$2.65 M14.9%
2025 A$2.3 M
2024 N/A-100%
2023 A$1.46 M-80.02%
2022 A$7.34 M-64.49%
2021 A$20.69 M
2020 N/A
2019 N/A
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA